Targeting CCR5 trafficking to inhibit HIV-1 infection

23Citations
Citations of this article
51Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Using a cell-based assay monitoring differential protein transport in the secretory pathway coupled to high-content screening, we have identified three molecules that specifically reduce the delivery of the major co-receptor for HIV-1, CCR5, to the plasma membrane. They have no effect on the closely related receptors CCR1 and CXCR4. These molecules are also potent in primary macrophages as they markedly decrease HIV entry. At the molecular level, two of these molecules inhibit the critical palmitoylation of CCR5 and thereby block CCR5 in the early secretory pathway. Our results open a clear therapeutics avenue based on trafficking control and demonstrate that preventing HIV infection can be performed at the level of its receptor delivery.

Cite

CITATION STYLE

APA

Boncompain, G., Herit, F., Tessier, S., Lescure, A., Nery, E. D., Gestraud, P., … Perez, F. (2019). Targeting CCR5 trafficking to inhibit HIV-1 infection. Science Advances, 5(10). https://doi.org/10.1126/sciadv.aax0821

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free